A new drug to treat postmenopausal women with advanced breast cancer has been approved by the U.S. Food and Drug Administration. Pfizer’s Ibrance (palbociclib) inhibits molecules that play a role in the growth of cancer cells. It is intended for ...

The U.S. Food and Drug Administration said on Wednesday it has approved a new device to treat obesity, the first since 2007. Known as the Maestro Rechargeable System, the device, made by EnteroMedics Inc, controls hunger and feelings of fullness ...